54 related articles for article (PubMed ID: 27174759)
1. [Autoreactive TCD8+ lymphocytes in patients with chronic myeloid leukemia in association with HLA and adenovirus infection].
Rivera SE; Echeverría M; Salcedo P; Márquez G; Carrillo Z; Parra Y; Cipriani AM; Núñez JR; Álvarez de Mon M; Farruco A
Rev Alerg Mex; 2016; 63(2):163-8. PubMed ID: 27174759
[TBL] [Abstract][Full Text] [Related]
2. [HLA DRB1*, DQB1*, DPA1*, and DPB1* and their association with the pathogenesis of leukemia in the population of Venezuela].
Rivera-Pirela SE; Echeverría M; Salcedo P; Márquez G; Carrillo Z; Parra Y; Cipriani AM; Núñez JR; Álvarez de Mon M
Rev Alerg Mex; 2016; 63(3):237-51. PubMed ID: 27560912
[TBL] [Abstract][Full Text] [Related]
3. Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects.
Butt NM; Rojas JM; Wang L; Christmas SE; Abu-Eisha HM; Clark RE
Haematologica; 2005 Oct; 90(10):1315-23. PubMed ID: 16219567
[TBL] [Abstract][Full Text] [Related]
4. The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantation.
Chen J; Schmitt A; Bunjes D; Chen B; Schmitt M
Int J Oncol; 2007 May; 30(5):1119-27. PubMed ID: 17390013
[TBL] [Abstract][Full Text] [Related]
5. HLA system affects the age-at-onset in chronic myeloid leukemia.
Oguz FS; Kalayoglu S; Diler AS; Tozkir H; Sargin D; Carin M; Dorak MT
Am J Hematol; 2003 Aug; 73(4):256-62. PubMed ID: 12879429
[TBL] [Abstract][Full Text] [Related]
6. HLA-DRB1*16-restricted recognition of myeloid cells, including CD34+ CML progenitor cells.
Ebeling SB; Ivanov R; Hol S; Aarts TI; Hagenbeek A; Verdonck LF; Petersen EJ
Br J Haematol; 2003 Jun; 121(5):721-9. PubMed ID: 12780786
[TBL] [Abstract][Full Text] [Related]
7. [Expression and analysis of HLA-A, B and DRB1 genes in patients with chronic myelogenous leukemia in Guangdong area].
Wei L; Xiao LL; Wu XY; Lin Q; Dong M; Wen JY; Ma XK; Chong F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):915-8. PubMed ID: 18718089
[TBL] [Abstract][Full Text] [Related]
8. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
[TBL] [Abstract][Full Text] [Related]
9. Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
Schmitt M; Li L; Giannopoulos K; Chen J; Brunner C; Barth T; Schmitt A; Wiesneth M; Döhner K; Döhner H; Greiner J
Exp Hematol; 2006 Dec; 34(12):1709-19. PubMed ID: 17157168
[TBL] [Abstract][Full Text] [Related]
10. BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.
Kessler JH; Bres-Vloemans SA; van Veelen PA; de Ru A; Huijbers IJ; Camps M; Mulder A; Offringa R; Drijfhout JW; Leeksma OC; Ossendorp F; Melief CJ
Leukemia; 2006 Oct; 20(10):1738-50. PubMed ID: 16932347
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-leukemia effects of Wilms' tumor 1 protein-specific cytotoxic T lymphocytes in patients with chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Wang ZD; Li D; Huang XJ
Chin Med J (Engl); 2010 Apr; 123(7):912-6. PubMed ID: 20497687
[TBL] [Abstract][Full Text] [Related]
12. Differential recognition of a BCR/ABL peptide by lymphocytes from normal donors and chronic myeloid leukemia patients.
Bertazzoli C; Marchesi E; Passoni L; Barni R; Ravagnani F; Lombardo C; Corneo GM; Pioltelli P; Pogliani E; Gambacorti-Passerini C
Clin Cancer Res; 2000 May; 6(5):1931-5. PubMed ID: 10815918
[TBL] [Abstract][Full Text] [Related]
13. Restricted TRBV repertoire in CD4+ and CD8+ T-cell subsets from CML patients.
Li Y; Geng S; Du X; Chen S; Yang L; Wu X; Li B; Schmidt CA; Przybylski GK
Hematology; 2011 Jan; 16(1):43-9. PubMed ID: 21269567
[TBL] [Abstract][Full Text] [Related]
14. [Activation of specific T lymphocyte induced by artificial antigen presenting cell complex in vitro].
Mao HW; Liu WL; Zhou JF; Geng Z; Huang W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):655-8. PubMed ID: 18549648
[TBL] [Abstract][Full Text] [Related]
15. Chronic myelogenous leukemia maintains specific CD8(+) T cells through IL-7 signaling.
Mumprecht S; Schürch C; Scherrer S; Claus C; Ochsenbein AF
Eur J Immunol; 2010 Oct; 40(10):2720-30. PubMed ID: 20836157
[TBL] [Abstract][Full Text] [Related]
16. A novel null HLA allele, HLA-DRB1*15:115N, identified in a Chinese family.
Li X; Zou H; Li M; Chen Q
Tissue Antigens; 2015 Jul; 86(1):69-70. PubMed ID: 25926086
[TBL] [Abstract][Full Text] [Related]
17. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
18. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
[TBL] [Abstract][Full Text] [Related]
19. Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells.
von dem Borne PA; van Luxemburg-Heijs SA; Heemskerk MH; Jedema I; Mulder A; Willemze R; Falkenburg JH
Leukemia; 2006 Jun; 20(6):1040-6. PubMed ID: 16525495
[TBL] [Abstract][Full Text] [Related]
20. Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes.
Buzyn A; Ostankovitch M; Zerbib A; Kemula M; Connan F; Varet B; Guillet JG; Choppin J
Eur J Immunol; 1997 Aug; 27(8):2066-72. PubMed ID: 9295046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
